arrow
H

Heather M. McLaughlin

pharming healthcare inc.
H指数:33
被引数:5,184

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PIGG variant pathogenicity assessment reveals characteristic features within 19 families
2021-10-018
OAAI
KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating
2021-07-1015
OA
De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy (Dec, 10.1038/s41436-020-01020-w, 2020)
2021-04-011
OAAI
Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K+ channelopathies
2021-02-1628
OAAI
De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders (vol 104, pg 139, 2019)

影响PP2A,PPP2CA的催化c α 亚基的从头突变会导致类似其他PP2A-Related神经发育障碍的综合征性智力障碍 (104卷,139页,2019页)

2019-02-0110
OAAI
De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders

影响PP2A,PPP2CA的催化c α 亚基的从头突变会导致类似其他PP2A-Related神经发育障碍的综合征性智力障碍

2019-01-0142
OAAI
Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

扩大BAF相关疾病的范围: SMARCC2的从头变体导致智力障碍和发育迟缓的综合征

2019-01-0163
OAAI